Structural nanomedicine — what helped give us the COVID vaccine — may now be the key to a potent blood cancer treatment that’s had remarkable early results.

Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most patients – and found a potential way to overcome that resistance. Team ...

A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone ...

It’s a new application for a cancer medicine that traditionally helps adults. But when it was given to young patients with the most common form of childhood leukemia, it was a game-changer. Every ...

DES MOINES, Iowa (KCCI) — When Madi Seivert was diagnosed with leukemia at age 3, her parents worried about her future. “Cancer is the last word any mom or dad wants to hear,” said Ashley Seivert. Now ...

A recently approved pill for leukemia can also help fight a deadly bone marrow disorder About 3 in 5 patients responded to olutasidenib Two-thirds were able to stop receiving regular blood ...

Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein complex, ensuring the cancer's survival. If one component of the complex is ...

Inotuzumab ozogamicin is an anti-CD22 antibody-drug conjugate that is approved for the treatment of relapsed or refractory precursor B-cell acute lymphoblastic leukemia (ALL). After binding CD22 on ...

A new once-a-day pill may help patients with an unusual form of leukemia live longer lives, doctors reported Saturday. Some of the patients given the pill, called Imbruvica, are still alive against ...